Skadden provided legal counsel to The Travelers Companies, Inc., while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian provided legal counsel to Corvus in the transaction. The...
Travelers’ $435 Million Acquisition of Corvus Insurance
Alimera Sciences’ Acquisition of U.S. Commercial Rights to YUTIQ®
Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...
HC9 Ventures’ Launch of $83 Million New Fund
Gunderson Dettmer represented HC9 Ventures on the deal. HC9 Ventures announced the launch of its $83 million new fund. HC9 focuses on early-stage healthcare software and services startups,...
Flywire’s IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP advised Flywire on the deal. Boston-based global payments enablement and software company, Flywire, announced its initial public offering. The company...
Corvus Insurance’s $100M Series C Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Corvus Insurance on the deal. Corvus Insurance, the leading provider of smart commercial insurance products powered by...